Below are key studies and publications that have significantly contributed to our current understanding of semaglutide, providing the evidence base for its clinical use, safety profile, and therapeutic implications
High responders were defined as people who lost more than 15% of their body weight during the study period
Researchers Call for Dedicated Early PsA Trials The review underscored that future studies should prioritize well-characterized early PsA cohorts, incorporate metabolic phenotyping, and evaluate potential synergistic effects when GLP-1RAs are combined with established biologics
People with more fat to lose see faster initial progress
Joint pain appears in some reports, though the causal relationship with tirzepatide is not firmly established
La Colombia copre il liraglutide per i casi di BMI elevato, ma impone un'autorizzazione preventiva a pi fasi